Preclinical Alzheimer’s disease biomarkers accurately predict cognitive and neuropathological outcomes is a research paper published in Brain (2022). On theSindex it has a DataRank of 0. It has been cited 46 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: K08AG068611
NIH
Grant: P30AG066444
NIH
Grant: P01AG03991
NIH
Grant: P01AG026276
Alzheimer’s Association
Grant: AACSF-18-564776
NIH HHS
Grant: S10 OD025214
NCATS NIH HHS
Grant: UL1 TR002345
NIA NIH HHS
Grant: K01 AG053474
NIA NIH HHS
Grant: P01 AG003991
Mary E. Groff Charitable Trust
FWCI
5.78
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer’s disease continuum
Additional file 1 of Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer’s disease continuum
Additional file 1 of Subjective cognitive concerns, APOE ε4, PTSD symptoms, and risk for dementia among older veterans
Additional file 1 of Subjective cognitive concerns, APOE ε4, PTSD symptoms, and risk for dementia among older veterans